DR LAL PATHLABS
Back to Balance Sheet
|
DR LAL PATHLABS Last 5 Year Total Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Liabilities | ₹2,345 Cr | ₹2,310 Cr | ₹1,633 Cr | ₹1,351 Cr | ₹1,069 Cr |
What is the latest Total Liabilities ratio of DR LAL PATHLABS ?
Year | Total Liabilities |
---|---|
Mar2023 | ₹2,345 Cr |
Mar2022 | ₹2,310 Cr |
Mar2021 | ₹1,633 Cr |
Mar2020 | ₹1,351 Cr |
Mar2019 | ₹1,069 Cr |
How is Total Liabilities of DR LAL PATHLABS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹2,345 Cr | 1.53 | |
Mar2022 | ₹2,310 Cr | 41.41 | |
Mar2021 | ₹1,633 Cr | 20.86 | |
Mar2020 | ₹1,351 Cr | 26.42 | |
Mar2019 | ₹1,069 Cr | - |
Compare Total Liabilities of peers of DR LAL PATHLABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR LAL PATHLABS | ₹19,346.5 Cr | -2.9% | 1.3% | 20.2% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹86,400.2 Cr | -4% | -6.9% | 31.8% | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹79,176.8 Cr | 1.5% | 0% | 77.6% | Stock Analytics | |
GLOBAL HEALTH | ₹37,886.4 Cr | -2.5% | 6.1% | 177% | Stock Analytics | |
FORTIS HEALTHCARE | ₹34,101.5 Cr | 1.8% | 5.5% | 69.1% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹25,542.0 Cr | -2% | -3.4% | 65.4% | Stock Analytics |
DR LAL PATHLABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR LAL PATHLABS | -2.9% |
1.3% |
20.2% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses